ArticleWorld journal of clinical cases2025
Acinar cystic transformation of the pancreas: A rare case report.
Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Acinar cystic transformation of pancreas as a rare cause of acute pancreatitis and a diagnostic challenge in a young male.Clinical journal of gastroenterology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcinar cystic transformation (ACT) of the pancreas is a rare non-neoplastic transformation of the pancreas. Adult women are the majority of patients with ACT, but few cases have been reported in pediatric patients. Given that there are currently no guidelines for the treatment of ACT, current treatment is based primarily on expert opinions and clinical experiences. Here, we report the case of the youngest child with ACT to date. Additionally, a literature review on pediatric ACT cases was performed to summarize previous clinical experience and treatment methods. CASE SUMMARY: A 1-year-old Chinese girl presented with progressive abdominal distension for 6 months. A detailed consultation revealed an uneventful history. The patient showed no signs of fever or abdominal pain and had a good appetite and normal feces. A mass of about 20 cm × 10 cm × 10 cm in size was detected in the abdomen. Both abdominal ultrasound and computed tomography examination revealed a multilocular cystic mass about 21.7 cm × 16.8 cm × 8.9 cm in size. At first, due to the large size and the possible retroperitoneal origin of the cyst, a total resection of the lesion was not possible. A single-port laparoscopic lymphangioma puncture and Pingyangmycin injection were performed in March 2023. One month after surgery, the abdominal cyst rapidly enlarged to its pre-operative size. After consulting with the experts in the angiology department and interventional department, sclerotherapy combined with oral sirolimus was performed in May 2023. After confirming that the tumor was not sensitive to sclerotherapy combined with oral sirolimus, our surgical team performed tumor reduction in August 2023. This surgery confirmed that the polycystic mass originated from the head of the pancreas, and pathological and immunohistochemical findings diagnosed pancreatic ACT. The patient showed no signs of cyst lesions after 6 months of follow-up and remains in good health up to the time of this report.
conclusionACT is a rare non-neoplastic transformation of the pancreas, more rarely seen in children. Manifestation and examinations show no specificity for diagnosis, and final diagnosis is mainly based on histological findings. To reach a specific diagnosis and rule out malignancy is a priority in clinical practice, and repeated biopsy or radical surgery should be considered before malignancy is ruled out. However, once a diagnosis of ACT is made, a conservative treatment with consecutive follow-up is recommended until symptoms present or obvious enlargement occurs because ACT is considered a slow-growing and benign tumor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.